Skip to main content
Journal cover image

Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention.

Publication ,  Journal Article
Barria Perez, AE; Rao, SV; Jolly, SJ; Pancholy, SB; Plourde, G; Rimac, G; Poirier, Y; Costerousse, O; Bertrand, OF
Published in: Am J Cardiol
April 15, 2016

Bivalirudin is an alternative to unfractionated heparin (UFH) anticoagulation during percutaneous coronary intervention. Previously, we have reported clinical benefit on major bleeding in favor of bivalirudin compared with UFH monotherapy but inconclusive results on mortality. Controversial data have been reported in the last 2 years. We conducted an updated meta-analysis including randomized trials and observational studies, which evaluated ischemic and bleeding outcomes for bivalirudin compared with UFH-only during percutaneous coronary intervention. We included 18 observational studies and 12 randomized trials published from 2003 to 2015. Primary outcomes were major adverse cardiovascular events within 30 days including death, myocardial infarction, and urgent revascularization and stent thrombosis, major bleeding, and transfusion. Overall, we found a significant risk reduction with bivalirudin for major bleeding (odds ratio [OR] 0.59, 95% confidence interval [CI] 0.49 to 0.71, p <0.0001) and for transfusion (OR 0.79, 95% CI 0.66 to 0.95, p = 0.01) and similar risk for major adverse cardiovascular events (OR 0.98, 95% CI 0.86 to 1.12, p = 0.80). However, there was a substantial increased risk of stent thrombosis associated with bivalirudin (OR 1.52, 95% CI 1.11 to 2.08, p = 0.009). No impact on mortality was found. Meta-regression analyses on major bleeding suggested that bivalirudin was more effective than UFH at doses >60 IU/kg and independent of radial access. In conclusion, compared with UFH monotherapy, bivalirudin remains associated with less bleeding risk but higher stent thrombosis risk. Further study remains required to define its role in current antithrombotic armamentarium.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Cardiol

DOI

EISSN

1879-1913

Publication Date

April 15, 2016

Volume

117

Issue

8

Start / End Page

1256 / 1266

Location

United States

Related Subject Headings

  • Thrombosis
  • Recombinant Proteins
  • Postoperative Hemorrhage
  • Percutaneous Coronary Intervention
  • Peptide Fragments
  • Myocardial Ischemia
  • Incidence
  • Humans
  • Hirudins
  • Heparin
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Barria Perez, A. E., Rao, S. V., Jolly, S. J., Pancholy, S. B., Plourde, G., Rimac, G., … Bertrand, O. F. (2016). Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention. Am J Cardiol, 117(8), 1256–1266. https://doi.org/10.1016/j.amjcard.2016.01.015
Barria Perez, Alberto E., Sunil V. Rao, Sanjit J. Jolly, Samir B. Pancholy, Guillaume Plourde, Goran Rimac, Yann Poirier, Olivier Costerousse, and Olivier F. Bertrand. “Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention.Am J Cardiol 117, no. 8 (April 15, 2016): 1256–66. https://doi.org/10.1016/j.amjcard.2016.01.015.
Barria Perez AE, Rao SV, Jolly SJ, Pancholy SB, Plourde G, Rimac G, et al. Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention. Am J Cardiol. 2016 Apr 15;117(8):1256–66.
Barria Perez, Alberto E., et al. “Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention.Am J Cardiol, vol. 117, no. 8, Apr. 2016, pp. 1256–66. Pubmed, doi:10.1016/j.amjcard.2016.01.015.
Barria Perez AE, Rao SV, Jolly SJ, Pancholy SB, Plourde G, Rimac G, Poirier Y, Costerousse O, Bertrand OF. Meta-Analysis of Effects of Bivalirudin Versus Heparin on Myocardial Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention. Am J Cardiol. 2016 Apr 15;117(8):1256–1266.
Journal cover image

Published In

Am J Cardiol

DOI

EISSN

1879-1913

Publication Date

April 15, 2016

Volume

117

Issue

8

Start / End Page

1256 / 1266

Location

United States

Related Subject Headings

  • Thrombosis
  • Recombinant Proteins
  • Postoperative Hemorrhage
  • Percutaneous Coronary Intervention
  • Peptide Fragments
  • Myocardial Ischemia
  • Incidence
  • Humans
  • Hirudins
  • Heparin